Dr. Reddy's Laboratories Limited Financials

Market Capitalization $12.42 Billion as of Jan. 1, 2025

Valuations Metrics as of Jan. 25, 2025

Trailing PE	18.38
Forward PE	16.26
Price to Sales TTM	$0.04
Price to Book MRQ	$0.04
Enterprise to Revenue	0.01
Enterprise to EBITDA	0.02

Financial Reports as of Sep. 30, 2024

Financials

Fiscal Year Ends	2024-03-31
Most Recent Quarter	2024-09-30
Profit Margin	17.79%
Operating Margin	22.51%
Return on Assets TTM	10.40%
Return on Equity TTM	19.27%

Income Statement

Revenue TTM	$3,475,536,347
Revenue per Share TTM	$60.14
Quarterly Revenue Growth	16.50%
Gross Profit TTM	$2,060,736,508
EBITDA	$83,416,000,000
Net Income to Common TTM	$618,131,701
Diluted EPS TTM	$0.77
Quarterly Earnings Growth YoY	-15.20%

Balance Sheet

Total Cash MRQ	$731,044,006
Total Cash per Share MRQ	$75.72
Total Debt MRQ	$
Total Debt to Equity MRQ	15.69
Current Ratio MRQ	1.92
Book Value per Share MRQ	$336.94

Cash Flow

Operating Cash Flow TTM	$394,868,536
Levered Free Cash Flow TTM	$87,558,612

RDY Stock Info as of Jan. 25, 2025

Stock Statistics

Shares Outstanding	833,121,024
Float Shares	599,476,678
Avg 10 Volume	2,582,594
Avg 30 Volume	None
Shares Short	13,111,803
Short Ratio	8.66
Short % of Shares	2.15%
% Held by Insiders	0.00%
% Held by Institutions	14.25%

Stock Price Summary

Beta	0.33
Fifty Two Week Low	$13.61
Fifty Two Week High	$16.89
Fifty Two Week Change	0.01%
Day 50 MA	$14.82
Day 200 MA	$15.17

Dividends and Splits

Forward Annual Dividend Rate	$1.92
Forward Annual Dividend Yield	13.68%
Trailing Annual Dividend Rate	$0.48
Trailing Annual Dividend Yield	3.42%
Payout Ratio	12.04%
Dividend Date	2024-08-12
Ex Dividend Date	2024-07-30
Last Split Factor
Last Split Date	2024-11-05